The Centers for Medicare & Medicaid Services is weighing whether to cover TAVI in asymptomatic severe aortic stenosis, as ...
A rethink for MINOCA, burn-out in imaging, AI cath lab prep, and the dyslipidemia guidelines: TCTMD journalists discuss their favorite stories.
Twenty years of data from New England highlight geographical challenges, which some say may merit a rethink of STEMI care.
The 2026 dyslipidemia guidelines offer “a chance to save lives at scale.” But statins alone can’t solve the problem.
Strait Access Technologies ( e-mail info@sat.za.com), a medical technology company developing next-generation cardiovascular ...
Absent contraindications, optimal medical therapy for heart failure with preserved ejection fraction (HFpEF) should include a ...
Experts hope the FAI score can become the next big tool in personalized risk assessment, though costs remain unknown.
The study serves as a reminder of what can happen when disease progresses in asymptomatic patients, David Cohen says.
With expectations to work after hours and a growing administrative burden, some say “radical” action is needed.
The US Food and Drug Administration has approved enlicitide (Lipfendra) as the first oral PCSK9 inhibitor for reducing LDL ...
More than half of US adults are eligible for primary prevention with statins, yet lipid-lowering therapies remain underused.
The pilot study provides “a good illustration of how AI can be an augmentation to our current processes,” Thomas Maddox says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results